Huang, Meng-ke
Yang, Yun-long
Hui, Lu
Chen, Xiao-lin
Liu, Ting
Jiang, Yong-mei
Funding for this research was provided by:
Sichuan Province Science and Technology Support Program (2023YFS0186, 2023YFS0222)
Clinical Research Foundation of West China Second University Hospital (KL076, KL066)
Article History
Received: 10 April 2024
Accepted: 19 August 2024
First Online: 21 August 2024
Declarations
:
: This study was approved by the Medicine Ethics Committee of West China Second University Hospital, Sichuan University (NO.2019-18). Broad consents were acquired before SAT analysis. For drug susceptibility analysis, we obtained the data from the Medical Records and Statistics Room hence informed consent waiver for this part of the study is approved by Medicine Ethics Committee of West China Second University Hospital, Sichuan University. We confirm that all methods were performed in accordance with the relevant guidelines and regulations.
: All authors approved the final version of the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
: The authors declare no competing interests.